Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:23:30.998Z.
Calculation as of: 2026-10-06T18:23:30.998Z.
Quote observation: 2026-10-06T18:15:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 42c577abd9d5aa4e94c21ca47db030ff1e5598993d2f9cb9fa7ffb886cc2a8f3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2018-05-15.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
OPERATING CASH FLOW YIELD AVG TTM
N/A
OPERATING CASH FLOW YIELD AVG 3Y
N/A
OPERATING CASH FLOW YIELD AVG 5Y
N/A
OPERATING CASH FLOW YIELD AVG 10Y
N/A
OPERATING CASH FLOW YIELD AVG 15Y
N/A
OPERATING CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Xenetic Biosciences, Inc.
Market Cap
$4.81M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.90M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.95M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.60M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.03M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.59M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.08M
Operating Cash Flow Yield
N/A
TTM Avg
7.23%
3Y Avg
6.60%
5Y Avg
6.60%
Market Cap
$4.51M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.12M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | $4.81M | N/A | N/A | N/A | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.90M | N/A | N/A | N/A | N/A |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.95M | N/A | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.60M | N/A | N/A | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.03M | N/A | N/A | N/A | N/A |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.59M | N/A | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.08M | N/A | 7.23% | 6.60% | 6.60% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.51M | N/A | N/A | N/A | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.12M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.37M | N/A | 3.14% | 3.14% | 3.14% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING CASH FLOW YIELD |
|---|---|
| 2018-05-15 | 9.05% |
| 2018-05-14 | 9.29% |
| 2018-05-11 | 9.10% |
| 2018-05-10 | 8.95% |
| 2018-05-09 | 8.43% |
| 2018-05-08 | 8.55% |
| 2018-05-07 | 7.64% |
| 2018-05-04 | 9.40% |
| 2018-05-03 | 9.50% |
| 2018-05-02 | 9.10% |
| 2018-05-01 | 9.97% |
